These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer. Oh HJ; Park ES; Kang S; Jo I; Jung SC Pediatr Res; 2004 Aug; 56(2):278-84. PubMed ID: 15181195 [TBL] [Abstract][Full Text] [Related]
4. Alternative therapies to address the unmet medical needs of patients with phenylketonuria. Blau N; Longo N Expert Opin Pharmacother; 2015 Apr; 16(6):791-800. PubMed ID: 25660215 [TBL] [Abstract][Full Text] [Related]
5. Phenylalanine hydroxylase genotype-phenotype associations in the United States: A single center study. Rajabi F; Rohr F; Wessel A; Martell L; Dobrowolski SF; Guldberg P; Güttler F; Levy HL Mol Genet Metab; 2019 Dec; 128(4):415-421. PubMed ID: 31623983 [TBL] [Abstract][Full Text] [Related]
6. A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria. Erlandsen H; Stevens RC J Inherit Metab Dis; 2001 Apr; 24(2):213-30. PubMed ID: 11405341 [TBL] [Abstract][Full Text] [Related]
7. Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: Results from a survey with 228 patients and their caregivers. Martins AM; Pessoa ALS; Quesada AA; Ribeiro EM Mol Genet Metab Rep; 2020 Sep; 24():100624. PubMed ID: 32742934 [TBL] [Abstract][Full Text] [Related]
8. New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride. Harding CO Biologics; 2010 Aug; 4():231-6. PubMed ID: 20714359 [TBL] [Abstract][Full Text] [Related]
9. Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now? Sarkissian CN; Gámez A Mol Genet Metab; 2005 Dec; 86 Suppl 1():S22-6. PubMed ID: 16165390 [TBL] [Abstract][Full Text] [Related]
10. Sapropterin dihydrochloride for phenylketonuria and tetrahydrobiopterin deficiency. Blau N Expert Rev Endocrinol Metab; 2010 Jul; 5(4):483-494. PubMed ID: 30780801 [TBL] [Abstract][Full Text] [Related]
11. Phenylalanine ammonia lyase (PAL): From discovery to enzyme substitution therapy for phenylketonuria. Levy HL; Sarkissian CN; Scriver CR Mol Genet Metab; 2018 Aug; 124(4):223-229. PubMed ID: 29941359 [TBL] [Abstract][Full Text] [Related]
12. Current Advances and Material Innovations in the Search for Novel Treatments of Phenylketonuria. Delbreil P; Dhondt S; Kenaan El Rahbani RM; Banquy X; Mitchell JJ; Brambilla D Adv Healthc Mater; 2024 Oct; 13(26):e2401353. PubMed ID: 38801163 [TBL] [Abstract][Full Text] [Related]
13. Mutational spectrum of the phenylalanine hydroxylase gene in patients with phenylketonuria in the central region of China. Zhang Z; Gao JJ; Feng Y; Zhu LL; Yan H; Shi XF; Chang AM; Shi Y; Wang P Scand J Clin Lab Invest; 2018 May; 78(3):211-218. PubMed ID: 29390883 [TBL] [Abstract][Full Text] [Related]
14. Phenylketonuria: a review of current and future treatments. Al Hafid N; Christodoulou J Transl Pediatr; 2015 Oct; 4(4):304-17. PubMed ID: 26835392 [TBL] [Abstract][Full Text] [Related]
15. New protein structures provide an updated understanding of phenylketonuria. Jaffe EK Mol Genet Metab; 2017 Aug; 121(4):289-296. PubMed ID: 28645531 [TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model. Diaz-Trelles R; Lee S; Kuakini K; Park J; Dukanovic A; Gonzalez JA; Dam T; Kim JH; Vega JB; Sablad M; Karmali PP; Tachikawa K; Chivukula P Mol Genet Metab Rep; 2022 Sep; 32():100882. PubMed ID: 35600090 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study. Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520 [TBL] [Abstract][Full Text] [Related]
18. Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice. Cacicedo ML; Weinl-Tenbruck C; Frank D; Limeres MJ; Wirsching S; Hilbert K; Pasha Famian MA; Horscroft N; Hennermann JB; Zepp F; Chevessier-Tünnesen F; Gehring S Front Bioeng Biotechnol; 2022; 10():993298. PubMed ID: 36277393 [TBL] [Abstract][Full Text] [Related]
19. Minimally invasive (13)C-breath test to examine phenylalanine metabolism in children with phenylketonuria. Turki A; Murthy G; Ueda K; Cheng B; Giezen A; Stockler-Ipsiroglu S; Elango R Mol Genet Metab; 2015; 115(2-3):78-83. PubMed ID: 25943030 [TBL] [Abstract][Full Text] [Related]
20. A novel approach for enzyme replacement therapy. The use of phenylalanine hydroxylase-based fusion proteins for the treatment of phenylketonuria. Eavri R; Lorberboum-Galski H J Biol Chem; 2007 Aug; 282(32):23402-9. PubMed ID: 17565982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]